Insulin Dosing Practices in Persons With Diabetes on Multiple Daily Injections

Completed

Conditions studied: Diabetes, Medication Adherence, Technology, Insulin

In brief

In this cross-sectional study the investigators will examine two populations: young adults with (ages 18-35) and older adults (ages 65 and over) with diabetes who are on \> 2 insulin injections per day. The sample size for this observational study will be up to 125 patients. The investigators will issue a Common Sensing GoCap bluetooth-enabled pen cap that fits on the end of Solostar Lantus and Apidra insulin pens; this pen cap registers the position of the insulin pen plunger and automatically sends confirmation of dose delivery to a smartphone app.

Key facts

Study ID

NCT02914730

Run by

Joslin Diabetes Center

People needed

75

Starts

2016-09-01

Expected to finish

2018-07-01

Last updated by the study team

2018-08-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 1 diabetes or insulin-requiring Type 2 diabetes
• > 2 insulin injections
• Age 18-35 or older than 65 years
• Use of glargine insulin as basal insulin
• Stable insulin doses for past 3 months

You may not qualify if…

• Previous tape/adhesive allergies with CGM sensors
• Visual or cognitive impairment with inability to self-administer insulin

Where it is running

• Joslin DIabetes Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.